Back
Esperion Therapeutics Stock Price Chart
Sell
50
ESPR
Esperion Therapeutics
Last Price:
2.35
Seasonality Move:
-7.21%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ESPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
Esperion Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.25 | Buy |
| 20-day SMA: | 2.11 | Buy |
| 50-day SMA: | 2.28 | Buy |
| 200-day SMA: | 1.83 | Buy |
| 8-day EMA: | 2.28 | Buy |
| 20-day EMA: | 2.21 | Buy |
| 50-day EMA: | 2.25 | Buy |
| 200-day EMA: | 2.26 | Buy |
Esperion Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 62.33 | Buy |
| Chaikin Money Flow: | 9884228 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.91 - 2.25) | Buy |
| Bollinger Bands (100): | (2.06 - 2.74) | Buy |
Esperion Therapeutics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Esperion Therapeutics Stock
Is Esperion Therapeutics Stock a Buy?
- Esperion Therapeutics share price is 2.59 while ESPR 8-day simple moving average is 2.25, which is a Buy signal.
- The stock price of ESPR is 2.59 while Esperion Therapeutics 20-day SMA is 2.11, which makes it a Buy.
- Esperion Therapeutics 50-day simple moving average is 2.28 while ESPR share price is 2.59, making it a Buy technically.
- ESPR stock price is 2.59 and Esperion Therapeutics 200-day simple moving average is 1.83, creating a Buy signal.
ESPR Technical Analysis vs Fundamental Analysis
Sell
50
Esperion Therapeutics (ESPR)
is a Sell
Is Esperion Therapeutics a Buy or a Sell?
-
Esperion Therapeutics stock is rated a Sell
The current Esperion Therapeutics [ESPR] share price is $2.59. The Score for ESPR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Esperion Therapeutics Stock Info
Market Cap:
490.7M
Price in USD:
2.59
Share Volume:
10.53M
Esperion Therapeutics 52-Week Range
52-Week High:
3.40
52-Week Low:
0.70
Sell
50
Esperion Therapeutics (ESPR)
is a Sell
Esperion Therapeutics Share Price Forecast
-
What is the Esperion Therapeutics stock price today?
The Esperion Therapeutics stock price is 2.59 USD today. -
Will ESPR stock go up or go down?
Esperion Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Esperion Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Esperion Therapeutics is overvalued.
Is Esperion Therapeutics Stock a Buy?
- Esperion Therapeutics share price is 2.59 while ESPR 8-day exponential moving average is 2.28, which is a Buy signal.
- The stock price of ESPR is 2.59 while Esperion Therapeutics 20-day EMA is 2.21, which makes it a Buy.
- Esperion Therapeutics 50-day exponential moving average is 2.25 while ESPR share price is 2.59, making it a Buy technically.
- ESPR stock price is 2.59 and Esperion Therapeutics 200-day simple moving average is 2.26, creating a Buy signal.
Fundamental Analysis of Esperion Therapeutics
Is Esperion Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.33 per share, an increase next quarter of $0.08 per share, an increase this year of $2.00 per share, and an increase next year of $0.23 per share.
Technical Analysis of Esperion Therapeutics
Should I short Esperion Therapeutics stock?
- ESPR Moving Average Covergence Divergence (MACD) indicator is 0.02, suggesting Esperion Therapeutics is a Buy
- Esperion Therapeutics Relative Strength Index (RSI) is 62.33, which suggest Esperion Therapeutics is overbought
- The Bollinger Bands (25) for Esperion Therapeutics is (1.91 - 2.25), which suggest Esperion Therapeutics is a Buy
- The Bollinger Bands (100) for Esperion Therapeutics is (2.06 - 2.74), which suggest Esperion Therapeutics is a Buy
* Esperion Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.